One of the listed companies, Beacon Pharmaceuticals PLC discloses its financial reports for the third quarter, (January – March 24).
The company’s earnings per share (EPS) was loss Tk 0.95 paisa in Q3 of the current financial year (January – March 24). EPS was loss Tk 0.04 paisa during the same period last year. As of March 31, 2024, at the end of the third quarter of the fiscal year, the company’s net asset value (NAV) per share stood at Tk 26.50.
